Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritis

(MedPage Today) -- PHILADELPHIA--Aimed at treating rheumatoid arthritis, an investigational antibody drug that stimulates checkpoint activity yielded good results in a phase II study reported here.
After 12 weeks, patients assigned to the...